Daiichi cues up mobile app for anticoagulant hopeful Savaysa; Novo Nordisk launches YouTube channel for diabetes ed;

> Canadian golfer Mike Weir is on the road in his home country touting Bayer's Aleve pain reliever as a remedy for arthritis. Report

> Digital health marketing agency Orchard has rolled out a global consumer platform for Bayer's prenatal vitamin Elevit. Report

> Novo Nordisk ($NVO) teamed up with a YouTube personality known for educational videos, Michael Stevens, to develop a new series focused on the science behind diabetes and its treatment. Release

> Daiichi Sankyo is working with Partners Healthcare's Center for Connected Health on a mobile app to coach atrial fibrillation patients soon to be using its prospective anticoagulant drug, Savaysa. Report

> European regulators recommended an update to the official labeling on Roche's ($RHHBY) new idiopathic pulmonary fibrosis drug Esbriet, which would add stronger efficacy claims and back up the drug's safety, the company said. Release

And Finally... Privately insured Americans spent more on medical care in 2013, in spite of the fact that they used fewer services. Release

Suggested Articles

The FDA's ad watchdog served its most serious violation to Alkermes Wednesday—and it took the unusual step of announcing that violation to the world.

Merck and Roche are no strangers to sparring with their I-O meds Keytruda and Tecentriq, but in TNBC, Keytruda's latest data take the prize.

Pfizer is doubling down on real-world data in HR-positive, HER2-negative breast cancer patients to boost its case for blockbuster Ibrance.